NCT07016438View on ClinicalTrials.gov

Clinical Study of PAL-222 Targeting Patients With Refractory Skin Ulcer

NARecruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

December 31, 2025

Conditions
Refractory Skin Ulcer
Interventions
PROCEDURE

Transplant surgery

One piece of PAL-222 is implanted into the ulcer area through the surgical procedure.

Trial Locations (1)

606-8507

RECRUITING

Kyoto University Hospital, Kyoto

Sponsors
All Listed Sponsors
lead

PharmaBio Corporation

INDUSTRY